Hepatic Drug Clearance: Effect of Protein Binding

Drugs with high extraction ratios are flow-limited and unaffected by protein binding during hepatic clearance. Conversely, drugs with low extraction ratios may be influenced by plasma protein binding, though the impact depends on the fraction of drug bound. This classification helps predict how changes in protein binding will affect a drug's hepatic metabolism.

Low extraction ratio drugs less than 80% protein-bound are capacity-limited and binding-insensitive, meaning small changes in protein binding have minimal effects on hepatic clearance. Highly protein-bound drugs are capacity-limited and binding-sensitive, where even slight alterations in protein binding significantly increase free drug concentration, elevating metabolism rate and hepatic clearance.

Propranolol has a high hepatic extraction ratio and relatively low plasma protein binding, classifying it as flow-limited. This means its hepatic clearance depends mainly on liver blood flow rather than enzyme activity or protein binding. Changes in liver perfusion significantly affect propranolol's metabolism and elimination from the body.

Warfarin has a low hepatic extraction ratio and high plasma protein binding, placing it near the capacity-limited, binding-sensitive corner of the triangular graph. For warfarin, hepatic clearance is influenced more by plasma protein binding and enzyme activity than by liver blood flow, making it sensitive to changes in protein binding and metabolic capacity.

The triangular graph categorizes drugs by plotting hepatic extraction ratio against percent plasma protein binding. Any drug metabolized and eliminated by the liver can be classified on this graph, revealing whether clearance is flow-limited, capacity-limited and binding-insensitive, or capacity-limited and binding-sensitive. This framework predicts how liver disease affects drug disposition.

Propranolol's clearance may decrease due to reduced blood flow in liver disease, while warfarin's clearance may change due to alterations in protein binding or enzyme activity. Understanding a drug's position on the triangular graph helps predict its behavior during hepatic dysfunction, enabling clinicians to anticipate disposition changes.

For capacity-limited, binding-sensitive drugs, small changes in plasma protein binding can cause substantial increases in free drug concentration. This occurs because a larger fraction of the drug becomes unbound and available for metabolism. The increased free drug concentration leads to elevated drug metabolism rate and enhanced hepatic clearance.